Yann Parc
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yann Parc has a total of 246 co-authors. Here are the top co-authors by number of shared publications:
- Jeremie H. Lefevre
Sorbonne Université, Department of Digestive Surgery, AP-HP, Hôpital Saint Antoine, F-75012, Paris, France
17 shared publications Clotilde Debove
Department of General and Digestive Surgery, Hôpital Saint Antoine, Assistance Publique – Hôpitaux de Paris (AP-HP), Sorbonne Université, Paris, France
5 shared publications- Maxime K. Collard
Department of Digestive Surgery, Hôpital Saint-Antoine, Sorbonne Université, Assistance publique-Hôpitaux de Paris, Paris, France
5 shared publications - Alexandre Challine
Department of Digestive Surgery, AP-HP, Hôpital Saint Antoine, Paris, France
4 shared publications Najim Chafai
Department of General and Digestive Surgery, Hôpital Saint Antoine, Assistance Publique – Hôpitaux de Paris (AP-HP), Sorbonne Université, Paris, France
4 shared publications- Andrea Lazzati
Department of General Surgery, Centre Hospitalier Intercommunal de Créteil, Créteil, France
3 shared publications
Latest Publications
- 5 November 2026
- Published by Elsevier in European Journal of Surgical Oncology
Surgery is still the gold standard for dMMR/MSI-H colon cancer
- 5 November 2026
- Published by Elsevier in European Journal of Surgical Oncology
Surgery is still the gold standard for dMMR/MSI-H colon cancer
- 13 October 2026
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
Duodenal Involvement in MUTYH-Associated Polyposis: Findings From An International Study and Implications for Endoscopic Surveillance
INTRODUCTION: This study aimed to better document incidence and progression of duodenal disease in MUTYH -associated polyposis (MAP). METHODS: Incidences of duodenal cancer, and duodenal polyposis by age and genotype were assessed in individuals with genetically confirmed MAP. RESULTS: At first endoscopy, 91/679 participants (13.4%) had duodenal adenoma(s) at a median age of 53 years (range 22–81 years). 439/679 participants had 1,367 further endoscopies, over a median period of 6.3 years (range 1 month–30 years). This included 365 without adenomas at first endoscopy, of whom 83 (22.7%) developed nonampullary adenomas during follow-up at a median age of 53 years (range 29–76). Thirty-eight adenomas (5.5%) contained high-grade dysplasia, of which 35 had a known size and 20 (57.1%) of these were 10 mm or smaller. Ampullary lesions were uncommon (31/679, 4.6%). Duodenal cancer was diagnosed in 5/679 participants (0.74%) at a median age of 65 years (range 47–83 years) and at a median of 12 months (range 9–24 months) after a surveillance endoscopy. At least 4 were located distally (in the third or fourth part). The cumulative incidences of duodenal adenomas and cancer at 70 years were 16.5%–63.5%, depending on genotype, and 0.58%, respectively. Adenoma incidence was significantly higher in Y179C (hazard ratio 5.33 [2.94–9.67, <0.001]) and E480X (4.07 [2.16–7.67, <0.001]) than G396D homozygotes. DISCUSSION: Future clinical guidelines for MAP should consider genotype-specific recommendations for duodenal surveillance, the importance of assessing the distal duodenum (i.e. D3, D4) and polypectomy of all detectable adenomas.
- 13 October 2026
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
Duodenal Involvement in MUTYH-Associated Polyposis: Findings From An International Study and Implications for Endoscopic Surveillance
INTRODUCTION: This study aimed to better document incidence and progression of duodenal disease in MUTYH -associated polyposis (MAP). METHODS: Incidences of duodenal cancer, and duodenal polyposis by age and genotype were assessed in individuals with genetically confirmed MAP. RESULTS: At first endoscopy, 91/679 participants (13.4%) had duodenal adenoma(s) at a median age of 53 years (range 22–81 years). 439/679 participants had 1,367 further endoscopies, over a median period of 6.3 years (range 1 month–30 years). This included 365 without adenomas at first endoscopy, of whom 83 (22.7%) developed nonampullary adenomas during follow-up at a median age of 53 years (range 29–76). Thirty-eight adenomas (5.5%) contained high-grade dysplasia, of which 35 had a known size and 20 (57.1%) of these were 10 mm or smaller. Ampullary lesions were uncommon (31/679, 4.6%). Duodenal cancer was diagnosed in 5/679 participants (0.74%) at a median age of 65 years (range 47–83 years) and at a median of 12 months (range 9–24 months) after a surveillance endoscopy. At least 4 were located distally (in the third or fourth part). The cumulative incidences of duodenal adenomas and cancer at 70 years were 16.5%–63.5%, depending on genotype, and 0.58%, respectively. Adenoma incidence was significantly higher in Y179C (hazard ratio 5.33 [2.94–9.67, <0.001]) and E480X (4.07 [2.16–7.67, <0.001]) than G396D homozygotes. DISCUSSION: Future clinical guidelines for MAP should consider genotype-specific recommendations for duodenal surveillance, the importance of assessing the distal duodenum (i.e. D3, D4) and polypectomy of all detectable adenomas.
- Open Access
- 10 August 2026
- Published by Elsevier in ESMO Gastrointestinal Oncology
- Vol. 13
Structured surveillance in Lynch syndrome: effectiveness, limitations, and unmet needs
- 10 August 2026
- Published by Elsevier in ESMO Gastrointestinal Oncology
- Vol. 13
Open AccessStructured surveillance in Lynch syndrome: effectiveness, limitations, and unmet needs
- Open Access
- 27 May 2026
- Published by Georg Thieme Verlag KG in Journal of Coloproctology
- Vol. 46 (02) , 001-008
CT Scan in the Postoperative Management of Colorectal Surgery Complications: Balancing Clinical Usefulness and Overuse
To evaluate whether computed tomography (CT) was overused in the early postoperative period in oncologic colorectal surgery. We conducted a single-center retrospective study including all patients who underwent colorectal resection with an anastomosis for colorectal adenocarcinoma between 2018 and 2022. The indications and findings of postoperative abdominopelvic CT scans performed during the initial hospital stay were collected, excluding the CT scans performed after discharge. A total of 1,091 patients were included. The overall morbidity rate was of 32%. Abdominopelvic CT scans were performed in 284 patients (26%), including 25% for isolated C-reactive protein (CRP) elevation without clinical signs. In total, 30% of the scans performed (n = 84) were normal, with 93% of those patients subsequently experiencing no severe postoperative complications. In cases of isolated CRP elevation, the rate of normal abdominopelvic CT scans was of 38%. In the multivariate analysis, we identified 3 factors associated with a normal abdominopelvic CT: scans performed within the first 4 postoperative days (p = 0.004), isolated CRP elevation (p = 0.010), and absence of a diverting ileostomy (p = 0.044). A predictive score based on these factors showed probabilities of a normal CT of 7%, 22%, 35%, and 54% when 0, 1, 2, or 3 factors were present respectively. Among patients with a normal scan, 39% were discharged within 24 hours, rising to 68% when the CT was performed for isolated CRP elevation. Postoperative abdominopelvic CT scans are frequently performed after colorectal surgery, with normal findings in about 1/3 of the cases in our experience. When normal—especially in the context of isolated CRP elevation—abdominopelvic CT scans exclude major complications and help accelerate an earlier and safe patient discharge.
- 27 May 2026
- Published by Georg Thieme Verlag KG in Journal of Coloproctology
- Vol. 46 (02) , 001-008
Open AccessCT Scan in the Postoperative Management of Colorectal Surgery Complications: Balancing Clinical Usefulness and Overuse
To evaluate whether computed tomography (CT) was overused in the early postoperative period in oncologic colorectal surgery. We conducted a single-center retrospective study including all patients who underwent colorectal resection with an anastomosis for colorectal adenocarcinoma between 2018 and 2022. The indications and findings of postoperative abdominopelvic CT scans performed during the initial hospital stay were collected, excluding the CT scans performed after discharge. A total of 1,091 patients were included. The overall morbidity rate was of 32%. Abdominopelvic CT scans were performed in 284 patients (26%), including 25% for isolated C-reactive protein (CRP) elevation without clinical signs. In total, 30% of the scans performed (n = 84) were normal, with 93% of those patients subsequently experiencing no severe postoperative complications. In cases of isolated CRP elevation, the rate of normal abdominopelvic CT scans was of 38%. In the multivariate analysis, we identified 3 factors associated with a normal abdominopelvic CT: scans performed within the first 4 postoperative days (p = 0.004), isolated CRP elevation (p = 0.010), and absence of a diverting ileostomy (p = 0.044). A predictive score based on these factors showed probabilities of a normal CT of 7%, 22%, 35%, and 54% when 0, 1, 2, or 3 factors were present respectively. Among patients with a normal scan, 39% were discharged within 24 hours, rising to 68% when the CT was performed for isolated CRP elevation. Postoperative abdominopelvic CT scans are frequently performed after colorectal surgery, with normal findings in about 1/3 of the cases in our experience. When normal—especially in the context of isolated CRP elevation—abdominopelvic CT scans exclude major complications and help accelerate an earlier and safe patient discharge.
- Open Access
- 14 March 2026
- Published by Elsevier in ESMO Gastrointestinal Oncology
- Vol. 12, 100319
Outcomes and management of primary tumors in metastatic MSI/dMMR colorectal cancer patients treated with immune checkpoint inhibitors: a cohort study
- 14 March 2026
- Published by Elsevier in ESMO Gastrointestinal Oncology
- Vol. 12, 100319
Open AccessOutcomes and management of primary tumors in metastatic MSI/dMMR colorectal cancer patients treated with immune checkpoint inhibitors: a cohort study
- 13 November 2025
- Published by Elsevier in Journal de Chirurgie Viscérale
- Vol. 162 (6) , 515-516
Réponse à Correspondance : « Confection d’un réservoir iléal en J et anastomose iléo-anale manuelle ou mécanique »
- 13 November 2025
- Published by Elsevier in Journal de Chirurgie Viscérale
- Vol. 162 (6) , 515-516
Réponse à Correspondance : « Confection d’un réservoir iléal en J et anastomose iléo-anale manuelle ou mécanique »
- Open Access
- 16 May 2024
- Published by Wiley in Colorectal Disease
- Vol. 26 (6) , 1203-1213
What is the rate of definitive stoma after subtotal colectomy for inflammatory bowel disease? A nationwide study of 1860 patients
Aim: Some patients with inflammatory bowel disease (IBD) require subtotal colectomy (STC) with ileostomy. The recent literature reports a significant number of patients who do not undergo subsequent surgery and are resigned to living with a definitive stoma. The aim of this work was to analyse the rate of definitive stoma and the cumulative incidence of secondary reconstructive surgery after STC for IBD in a large national cohort study.Method: A national retrospective study (2013–2021) was conducted on prospectively collected data from the French Medical Information System Database (PMSI). All patients undergoing STC in France were included. The association between definitive stoma and potential risk factors was studied using univariate and multivariate analyses.Results: A total of 1860 patients were included (age 45 ± 9 years; median follow‐up 30 months). Of these, 77% (n = 1442) presented with ulcerative colitis. Mortality and morbidity at 90 days after STC were 5% (n = 100) and 47% (n = 868), respectively. Reconstructive surgery was identified in 1255 patients (67%) at a mean interval of 7 months from STC. Seveny‐four per cent (n = 932) underwent a completion proctectomy with ileal pouch anal anastomosis and 26% (n = 323) an ileorectal anastomosis. Six hundred and five (33%) patients with a definitive stoma had an abdominoperineal resection (n = 114; 19%) or did not have any further surgical procedure (n = 491; 81%). Independent risk factors for definitive stoma identified in multivariate analysis were older age, Crohn's disease, colorectal neoplasia, postoperative complication after STC, laparotomy and a low‐volume hospital.Conclusion: We found that 33% of patients undergoing STC with ileostomy for IBD had definitive stoma. Modifiable risk factors for definitive stoma were laparotomy and a low‐volume hospital.
- 16 May 2024
- Published by Wiley in Colorectal Disease
- Vol. 26 (6) , 1203-1213
Open AccessWhat is the rate of definitive stoma after subtotal colectomy for inflammatory bowel disease? A nationwide study of 1860 patients
Aim: Some patients with inflammatory bowel disease (IBD) require subtotal colectomy (STC) with ileostomy. The recent literature reports a significant number of patients who do not undergo subsequent surgery and are resigned to living with a definitive stoma. The aim of this work was to analyse the rate of definitive stoma and the cumulative incidence of secondary reconstructive surgery after STC for IBD in a large national cohort study.Method: A national retrospective study (2013–2021) was conducted on prospectively collected data from the French Medical Information System Database (PMSI). All patients undergoing STC in France were included. The association between definitive stoma and potential risk factors was studied using univariate and multivariate analyses.Results: A total of 1860 patients were included (age 45 ± 9 years; median follow‐up 30 months). Of these, 77% (n = 1442) presented with ulcerative colitis. Mortality and morbidity at 90 days after STC were 5% (n = 100) and 47% (n = 868), respectively. Reconstructive surgery was identified in 1255 patients (67%) at a mean interval of 7 months from STC. Seveny‐four per cent (n = 932) underwent a completion proctectomy with ileal pouch anal anastomosis and 26% (n = 323) an ileorectal anastomosis. Six hundred and five (33%) patients with a definitive stoma had an abdominoperineal resection (n = 114; 19%) or did not have any further surgical procedure (n = 491; 81%). Independent risk factors for definitive stoma identified in multivariate analysis were older age, Crohn's disease, colorectal neoplasia, postoperative complication after STC, laparotomy and a low‐volume hospital.Conclusion: We found that 33% of patients undergoing STC with ileostomy for IBD had definitive stoma. Modifiable risk factors for definitive stoma were laparotomy and a low‐volume hospital.
- Open Access
- 18 June 2023
- Published by Elsevier in EJC Skin Cancer
- Vol. 1
Molecular profiling of anal Paget’s disease and underlying anal adenocarcinoma highlights their common origin
- 18 June 2023
- Published by Elsevier in EJC Skin Cancer
- Vol. 1
Open AccessMolecular profiling of anal Paget’s disease and underlying anal adenocarcinoma highlights their common origin